Concordant Surgical Treatment: Non-melanocytic Skin Cancer of the Head and Neck |
Ryu, Wan Cheol
(Department of Plastic and Reconstructive Surgery, Konyang Hospital, Konyang University School of Medicine)
Koh, In Chang (Department of Plastic and Reconstructive Surgery, Konyang Hospital, Konyang University School of Medicine) Lee, Yong Hae (Department of Plastic and Reconstructive Surgery, Konyang Hospital, Konyang University School of Medicine) Cha, Jong Hyun (Department of Plastic and Reconstructive Surgery, Konyang Hospital, Konyang University School of Medicine) Kim, Sang Il (Department of Plastic and Reconstructive Surgery, Konyang Hospital, Konyang University School of Medicine) Kim, Chang Gyun (Department of Plastic and Reconstructive Surgery, Konyang Hospital, Konyang University School of Medicine) |
1 | Kauvar AN, Arpey CJ, Hruza G, Olbricht SM, Bennett R, Mahmoud BH. Consensus for Nonmelanoma Skin Cancer Treatment, Part II: Squamous Cell Carcinoma, Including a Cost Analysis of Treatment Methods. Dermatol Surg 2015;41:1214-40. |
2 | Choi JH, Kim YJ, Kim H, Nam SH, Choi YW. Distribution of Basal cell carcinoma and squamous cell carcinoma by facial esthetic unit. Arch Plast Surg 2013;40:387-91. |
3 | Durham AB, Lowe L, Malloy KM, McHugh JB, Bradford CR, Chubb H, et al. Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma on the Head and Neck. JAMA Otolaryngol Head Neck Surg 2016;142:1171-6. |
4 | Fujimoto M, Yamamoto Y, Matsuzaki I, Warigaya K, Iwahashi Y, Kojima F, et al. Tumor budding is an independent risk factor for lymph node metastasis in cutaneous squamous cell carcinoma: a single center retrospective study. J Cutan Pathol 2016;43:766-71. |
5 | National Comprehensive Cancer Network. Squamous cell carcinoma NCCN clinical pracice guidelines [Internet]. Washington, PA: National Comprehensive Cancer Network; 2016 [cited 2017 Mar 11]. Available from: https://www.nccn.org/professionals/physician_gls/f_ guidelinesnojava.asp. |
6 | O'Bryan K, Sherman W, Niedt GW, Taback B, Manolidis S, Wang A, et al. An evolving paradigm for the workup and management of highrisk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2013;69:595-602.e1. |
7 | Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013;68:957-66. |
8 | Shin JH, Cho S, Whang KK, Hahm JH. An epidemiologic analysis of cutaneous malignant tumors over 15 years (1984-1998). Korean J Dermatol 1999;37:1743-51. |
9 | Kauvar AN, Cronin T Jr, Roenigk R, Hruza G, Bennett R. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg 2015;41:55071. |
10 | Ratner D. Surgical management of local basal cell carcinoma. In: Miller SJ, Maloney ME, editors. Cutaneous oncology: pathophysiology, diagnosis, and management. Malden, MA: Blackwell Science; 1998. p.664-71. |
11 | Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001;344:975-83. |
12 | Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64:1051-9. |
13 | Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649-62. |
14 | Miura H, Ono S, Shibutani K, Seino H, Tsushima F, Kakehata S, et al. Contribution of dynamic sentinel lymphoscintigraphy images to the diagnosis of patients with malignant skin neoplasms in the upper and lower extremities. Springerplus 2014;3:625. |
15 | Parikh SA, Patel VA, Ratner D. Advances in the management of cutaneous squamous cell carcinoma. F1000Prime Rep 2014;6:70. |
16 | Iorio ML, Ter Louw RP, Kauffman CL, Davison SP. Evidence-based medicine: facial skin malignancy. Plast Reconstr Surg 2013;132:163143. |
![]() |